Light Therapy Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Light Therapy interacts with medications. The heart of this page is the interaction list — every drug Light Therapy is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Light Therapy is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Light Therapy against your medication
Add one medicationLight Therapy Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Light Therapy drug interaction appears low for most people, and the entire profile comes down to one concern: medicines that increase sensitivity to light. None of the listed interactions are rated major, and although they are all graded moderate, every one rests on the same limited, largely theoretical evidence.
The one category that stands out is photosensitizing drugs, meaning medications that make the skin or eyes more sensitive to light. Combining these with light therapy may raise the chance of a phototoxic reaction, essentially a harmful skin response to light, and the data indicates this combination should be avoided. Keep in mind, though, that this concern is graded as possible, based on limited research rather than well-controlled human studies.
Although a few hundred medications appear on this list, they are all there for the same single reason: each can heighten sensitivity to light. That does not mean every combination has caused harm in people. The risk is predicted from how these drugs behave rather than proven by strong clinical evidence, so a listing signals caution, not a guaranteed reaction.
Based on HelloPharmacist’s Light Therapy interaction data and reviewed under our editorial standards.
Drugs that interact with Light Therapy
335 medications have a known interaction with Light Therapy, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Light Therapy using our pharmacist-reviewed interaction data.
AI summaries are generated from our Light Therapy interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Light Therapy combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Light Therapy affects
Every type of medication (drug category) Light Therapy is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Photosensitizing Drugs
Light therapy may increase the risk for photosensitization.
Concomitant use of photosensitizing drugs with light therapy may increase the risk for phototoxicity and should be avoided.
Light Therapy: Uses, Safety & Side Effects
Light therapy uses controlled exposure to bright artificial light and is best supported for seasonal affective disorder, where it is a recognized treatment option. It is generally safe for most people when used as directed, but you should talk to a doctor or pharmacist first, especially if you have eye conditions, bipolar disorder, or take medicines that increase light sensitivity.
- Part used
- Not applicable (light exposure, not a plant)
- Common forms
- Light boxes, dawn-simulating alarm clocks, light visors, wearable light devices, blue/red light panels
- Seasonal affective disorder (SAD)
- Non-seasonal depression
- Sleep and circadian rhythm problems
- Jet lag and shift-work sleep issues
- Certain skin conditions
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated, but certain eye, skin, and mood conditions need medical guidance.
When bright light therapy is used short-term. Other types of light therapies, especially PUVA, have not been extensively evaluated in pregnancy or lac...
Read the full pregnancy detailWhen bright light therapy is used short-term. Other types of light therapies, especially PUVA, have not been extensively evaluated in pregnancy or lac...
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Light therapy (also called phototherapy or bright-light therapy) is a treatment that uses controlled exposure to artificial light. Unlike herbs or supplements, it is not something you swallow — it is a device you sit near or wear for a set amount of time.
The most common type uses a light box that gives off bright white light, usually around 10,000 lux, while filtering out most ultraviolet (UV) rays. People often use it in the morning. Other forms include dawn-simulating alarm clocks, light visors, and colored-light panels (such as blue or red light) used for skin or other purposes.
Light therapy is most widely known for treating seasonal affective disorder (SAD), a type of depression that comes back during the darker fall and winter months. It is also used for some sleep, mood, and skin conditions.
How it works
Light is the main signal that sets the body's internal clock, called the circadian rhythm. Special cells in the eye sense bright light and send signals to the brain that help control alertness, sleep, and mood.
Bright light in the morning is thought to help reset this clock and may influence brain chemicals such as serotonin and the sleep hormone melatonin. By doing this, light therapy may improve mood and help align sleep timing.
For skin-focused phototherapy, different wavelengths are believed to work in different ways — for example, by slowing overactive skin cells or targeting bacteria. Much of the detailed science behind these effects continues to be studied.
Does Light Therapy work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Effective Neonatal jaundice
Light therapy reduces bilirubin levels in the treatment of neonatal jaundice.
Effective Psoriasis
Light therapy, including ultraviolet B (UVB) or psoralens with ultraviolet A (PUVA), is effective for the treatment of psoriasis.
Effective Seasonal affective disorder (SAD)
Light therapy is effective in the treatment of SAD.
Likely Effective Atopic dermatitis (eczema)
Ultraviolet A (UVA) and ultraviolet B (UVB) light therapy improves symptoms of eczema.
Likely Effective Mycosis fungoides
Light therapy is effective for the treatment of mycosis fungoides.
Possibly Effective Bipolar disorder
Light therapy seems to improve symptoms of bipolar depression.
Possibly Effective Circadian rhythm sleep disorders
Light therapy seems to be beneficial for sleep-wake cycle disturbances, including circadian rhythm sleep disorder.
Possibly Effective Herpes labialis (cold sores)
Narrow waveband light therapy reduces the time to healing of cold sores.
Possibly Effective Pruritus
Ultraviolet B (UVB) light therapy reduces uremic pruritus in patients with kidney failure.
Possibly Effective Scleroderma
Light therapy, including broadband ultraviolet A (UVA/UVA1) light therapy, improves symptoms in patients with localized scleroderma.
Possibly Effective Vitiligo
Light therapy seems to improve re-pigmentation in patients with vitiligo, when used alone or in combination with other treatments.
Also studied for 39 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Acantholytic disorders
It is unclear if light therapy is beneficial for the treatment of Grover disease.
Insufficient Reliable Evidence To Rate Acne
It is unclear if light therapy is beneficial for the treatment of acne; the available clinical research has yielded mixed findings.
Insufficient Reliable Evidence To Rate Allergic rhinitis (hay fever)
It is unclear if endonasal light therapy is beneficial in patients with allergic rhinitis.
Insufficient Reliable Evidence To Rate Alopecia areata
It is unclear if light therapy is beneficial in patients with alopecia areata.
Insufficient Reliable Evidence To Rate Alzheimer disease
It is unclear if light therapy is beneficial in patients with Alzheimer disease.
Insufficient Reliable Evidence To Rate Androgenic alopecia
Low-level light therapy seems to improve hair density and thickness in patients with androgenic alopecia.
Insufficient Reliable Evidence To Rate Anorexia nervosa
It is unclear if light therapy is beneficial in people with anorexia nervosa.
Insufficient Reliable Evidence To Rate Bulimia nervosa
Bright light therapy might improve well-being and eating problems in patients with bulimia nervosa.
Insufficient Reliable Evidence To Rate Cancer-related fatigue
It is unclear if light therapy is beneficial for cancer-related fatigue.
Insufficient Reliable Evidence To Rate Cognitive impairment
It is unclear if light therapy is beneficial in patients with cognitive impairments.
Insufficient Reliable Evidence To Rate Coronavirus disease 2019 (COVID-19)
It is unclear if light therapy is beneficial for COVID-19.
Insufficient Reliable Evidence To Rate Delirium
It is unclear if dynamic light therapy can reduce delirium in patients in the intensive care unit.
Insufficient Reliable Evidence To Rate Dementia
It is unclear if light therapy is beneficial in patients with dementia.
Insufficient Reliable Evidence To Rate Diabetic foot ulcers
Light therapy might improve the healing of diabetic foot ulcers.
Insufficient Reliable Evidence To Rate Dry eye
It is unclear if light therapy is beneficial for dry eye.
Insufficient Reliable Evidence To Rate Dysmenorrhea
Preliminary clinical research suggests that low-level light therapy might improve symptoms of dysmenorrhea.
Insufficient Reliable Evidence To Rate Exercise-induced muscle soreness
Light therapy does not seem to improve exercise-induced muscle soreness.
Insufficient Reliable Evidence To Rate Fibromyalgia
It is unclear if bright light therapy improves symptoms of fibromyalgia.
Insufficient Reliable Evidence To Rate Graft-versus-host disease (GVHD)
Although there has been interested in using light therapy for GVHD, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Herpes zoster (shingles)
It is unclear if broadband ultraviolet B (UVB) light therapy improves healing of herpes zoster rash.
Insufficient Reliable Evidence To Rate Human papillomavirus (HPV)
It is unclear if red light therapy is beneficial in patients with subclinical or latent HPV infection when used in combination with high-dose interferon.
Insufficient Reliable Evidence To Rate Lichen planus
It is unclear if light therapy is beneficial in patients with lichen planus.
Insufficient Reliable Evidence To Rate Multiple sclerosis (MS)
Although there has been interest in using light therapy for MS, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Myopia
It is unclear if light therapy is beneficial in patients with myopia.
Insufficient Reliable Evidence To Rate Onychomycosis
It is unclear if light therapy is beneficial for resolution of onychomycosis.
Insufficient Reliable Evidence To Rate Pain (chronic)
Although there has been interest in using light therapy for chronic pain, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Parkinson disease
It is unclear if bright light therapy is beneficial in patients with Parkinson disease; the available research is conflicting.
Insufficient Reliable Evidence To Rate Pemphigus
Although there has been interest in using light therapy for pemphigus, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Peripheral neuropathy
Although there has been interest in using light therapy for peripheral neuropathy, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Pityriasis lichenoides chronica (PLC)
It is unclear if light therapy is beneficial in patients with PLC.
Insufficient Reliable Evidence To Rate Postpartum depression
It is unclear if light therapy is beneficial in patients with postpartum depression.
Insufficient Reliable Evidence To Rate Premenstrual dysphoric disorder (PMDD)
It is unclear if light therapy is beneficial in patients with PMDD.
Insufficient Reliable Evidence To Rate Pressure ulcers
Ultraviolet (UV) light therapy might improve the healing of pressure ulcers.
Insufficient Reliable Evidence To Rate Sleep deprivation
Bright light therapy has only been evaluated in combination with caffeine; its effect when used alone is unclear.
Insufficient Reliable Evidence To Rate Traumatic brain injury (TBI)
Light therapy does not seem beneficial in patients with TBI.
Insufficient Reliable Evidence To Rate Tuberculosis
Although there has been interest in using light therapy for tuberculosis, there is insufficient reliable information about the clinical effects of light therapy for this purpose.
Insufficient Reliable Evidence To Rate Urticaria
It is unclear if light therapy is beneficial in patients with chronic urticaria.
Insufficient Reliable Evidence To Rate Warts
It is unclear if light therapy is beneficial for the resolution of warts.
Insufficient Reliable Evidence To Rate Wound healing
It is unclear if light therapy is beneficial for wound healing.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
Light therapy is generally safe for most people when devices are used as directed and filter out UV light. Still, some people should be careful.
Talk to a doctor first if you: have an eye disease or are at risk for one (such as macular degeneration, glaucoma, or diabetic eye problems), have bipolar disorder (bright light can sometimes trigger mania or agitation), have a skin condition that worsens with light, or take any medicine or supplement that increases sensitivity to light.
Pregnancy and breastfeeding: Bright-light therapy is often viewed as a low-risk option and is sometimes considered for depression during these times, but specific safety data are limited. Use it only under the supervision of your doctor.
Choose a device designed for the purpose you have in mind, and follow the manufacturer's instructions for distance, timing, and duration.
Side effects
Side effects are usually mild and often improve by lowering the brightness, moving farther from the device, or shortening sessions. They can include:
- Headache
- Eye strain or eye irritation
- Nausea
- Feeling wired, jittery, or irritable
- Trouble sleeping, especially if used too late in the day
Rarely, in people with bipolar disorder, bright light may trigger an episode of mania, agitation, or rapid mood changes. If you notice unusual mood swings, stop and contact your doctor. UV-filtered light boxes carry little skin or eye risk, but devices that emit UV require closer medical supervision.
Light Therapy: Reported Adverse Effects
Documented safety reports on Light Therapy from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Phototherapy seems to be well tolerated when used appropriately.
Most Common Adverse Effects:
Mild burning, nausea, phototoxicity, pruritus, and redness.
Serious Adverse Effects (Rare):
Hypomania or mania, skin cancers such as squamous cell carcinoma.
Allergic rhinitis (hay fever) Immunologic
Exposure to light therapy for more than 24 hours as an infant is linked to higher odds of developing food allergies and other allergic disorders later in childhood.
Anxiety Psychiatric
Light therapy may cause agitation, and rarely hypomania or mania. Jumpiness, jitteriness, nervousness, irritability, anxiety, delusions, and aggressive behavior has been reported in patients with dementia.
- Tuunainen, A., Kripke, D. F., and Endo, T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004;(2):CD004050.
- Chesson, A. L., Jr., Littner, M., Davila, D., Anderson, W. M., Grigg-Damberger, M., Hartse, K., Johnson, S., and Wise, M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Acade
- Terman, M. and Terman, J. S. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60(11):799-808.
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591.
Cancer Oncologic
There is some concern that long-term use of psoralens and UVA (PUVA) may increase the risk of skin cancers such as squamous cell carcinoma. However, most research has found that long-term UVA and UVB phototherapy, without psoralens, is not associated with an increased risk of skin cancer and that UVB and PUVA phototherapy might not increase the risk of skin cancer in non-Caucasian patients. Also, in patients with vitiligo, a meta-analysis of observational research has found that UVB and/or PUVA light therapy are not associated with skin cancer risk, regardless of ethnicity or number of treatment sessions. However, only five studies were included in the analysis. Additionally, other research using a cancer registry database found no association between whole-body UVA1 phototherapy and risk of basal cell carcinoma, squamous cell carcinoma, melanoma, non-Hodgkin's lymphoma, or prostate cancer during follow-up of up to 20 years.
Some observational research suggests that exposure to light therapy as a neonate, most often for hyperbilirubinemia, is associated with greater odds of cancer. However, most of these studies did not adjust for confounding variables or determine whether the intensity or duration of light therapy alters risk.
- Morison, W. L., Baughman, R. D., Day, R. M., Forbes, P. D., Hoenigsmann, H., Krueger, G. G., Lebwohl, M., Lew, R., Naldi, L., Parrish, J. A., Piepkorn, M., Stern, R. S., Weinstein, G. D., and Whitmore, S. E. Consensus workshop on the toxic effects of long
- Stern, R. S. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66(4):553-562.
- Stern, R. S. and Lunder, E. J. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 1998;134(12):1582-1585.
- Swerdlow, A. J. and Weinstock, M. A. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998;38(1):89-98.
- Lee, E., Koo, J., and Berger, T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 2005;44(5):355-360.
- Murase, J. E., Lee, E. E., and Koo, J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005;44(12):1016-1021.
- Ju HJ, Han JH, Kim MS, et al. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo. J Am Acad Dermatol 2021;84(6):1619-1627.
- Ko MJ, Huang JW, Wu HY, et al. Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study. Acta Derm Venereol 2021;101(2):adv00390.
- Ravindran S, Pai B S, Shetty VM. Risk of cutaneous carcinogenesis with phototherapy in Indian subpopulation: A 10-year analysis and a review of literature. Dermatol Ther 2022;35(7):e15536.
- Ahad T, Wang EY, Liu YA, et al. Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy. J Am Acad Dermatol 2022;87(2):387-389.
- Wu YH, Chou CL, Chang HC. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis. Clin Exp Dermatol 2022;47(4):692-699.
- Bedair K, Elhadad A, Hamad S, Ferguson J, Donnan P, Dawe RS. No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study. Br J Dermatol. 2020;183(3):586-7.
- Bugaiski-Shaked A, Shany E, Mesner O, Sergienko R, Wainstock T. Association between neonatal phototherapy exposure and childhood neoplasm. J Pediatr 2022;245:111-116.
- Abdellatif M, Tawfik GM, Makram AM, et al. Association between neonatal phototherapy and future cancer: an updated systematic review and meta-analysis. Eur J Pediatr 2023;182(1):329-341.
Cancer Dermatologic
UV phototherapy may cause xerosis, pruritus, hyperpigmentation, photoaging, blisters, mild burning, redness, erosion, erythema, moderate heat sensation, skin dryness, thinning of skin (atrophy), sweating, flushing, and phototoxicity. Long-term exposure to ultraviolet radiation may cause actinic damage and premature skin aging. Folliculitis has occurred in patients undergoing psoralens with UVA therapy (PUVA).
There is some concern that long-term use of PUVA may increase the risk of skin cancers such as squamous cell carcinoma. However, most research has found that long-term UVA and UVB phototherapy, without psoralens, is not associated with an increased risk of skin cancer and that UVB and PUVA phototherapy might not increase the risk of skin cancer in non-Caucasian patients. Also, in patients with vitiligo, a meta-analysis of observational research has found that UVB and/or PUVA light therapy are not associated with skin cancer risk, regardless of ethnicity or number of treatment sessions. However, only five studies were included in the analysis. Additionally, other research using a cancer registry database found no association between whole-body UVA1 phototherapy and risk of basal cell carcinoma, squamous cell carcinoma, or melanoma during follow-up of up to 20 years.
- Meduri, N. B., Vandergriff, T., Rasmussen, H., and Jacobe, H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007;23(4):106-112.
- Pathirana, D., Ormerod, A. D., Saiag, P., Smith, C., Spuls, P. I., Nast, A., Barker, J., Bos, J. D., Burmester, G. R., Chimenti, S., Dubertret, L., Eberlein, B., Erdmann, R., Ferguson, J., Girolomoni, G., Gisondi, P., Giunta, A., Griffiths, C., Honigsmann
- Leon, A., Nguyen, A., Letsinger, J., and Koo, J. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options. Expert Opin Pharmacother 2007;
- Kroft, E. B., Berkhof, N. J., van de Kerkhof, P. C., Gerritsen, R. M., and de Jong, E. M. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008;59(6):1017-1030.
- Chesson, A. L., Jr., Littner, M., Davila, D., Anderson, W. M., Grigg-Damberger, M., Hartse, K., Johnson, S., and Wise, M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Acade
- Morgan, M. and Khan, D. A. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol 2008;100(6):517-526.
- Hoare, C., Li Wan, Po A., and Williams, H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4(37):1-191.
- Whitton, M. E., Pinart, M., Batchelor, J., Lushey, C., Leonardi-Bee, J., and Gonzalez, U. Interventions for vitiligo. Cochrane Database Syst Rev 2010;(1):CD003263.
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591.
- Zhu S, Ma X, Ding X, et al. Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective ra
- Ravindran S, Pai B S, Shetty VM. Risk of cutaneous carcinogenesis with phototherapy in Indian subpopulation: A 10-year analysis and a review of literature. Dermatol Ther 2022;35(7):e15536.
- Agaoglu E, Erdogan HK, Acer E, Saracoglu ZN, Bilgin M. Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real-life experience. Photodermatol Photoimmunol Photomed 2023;39(5):520-526.
- Beani, J. C. and Jeanmougin, M. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]. Ann Dermatol Venereol 2010;137(1):21-31.
- Morison, W. L., Baughman, R. D., Day, R. M., Forbes, P. D., Hoenigsmann, H., Krueger, G. G., Lebwohl, M., Lew, R., Naldi, L., Parrish, J. A., Piepkorn, M., Stern, R. S., Weinstein, G. D., and Whitmore, S. E. Consensus workshop on the toxic effects of long
- Stern, R. S. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66(4):553-562.
- Stern, R. S. and Lunder, E. J. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 1998;134(12):1582-1585.
- Swerdlow, A. J. and Weinstock, M. A. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998;38(1):89-98.
- Lee, E., Koo, J., and Berger, T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 2005;44(5):355-360.
- Murase, J. E., Lee, E. E., and Koo, J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005;44(12):1016-1021.
- Ju HJ, Han JH, Kim MS, et al. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo. J Am Acad Dermatol 2021;84(6):1619-1627.
- Ko MJ, Huang JW, Wu HY, et al. Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study. Acta Derm Venereol 2021;101(2):adv00390.
- Ahad T, Wang EY, Liu YA, et al. Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy. J Am Acad Dermatol 2022;87(2):387-389.
- Wu YH, Chou CL, Chang HC. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis. Clin Exp Dermatol 2022;47(4):692-699.
- Bedair K, Elhadad A, Hamad S, Ferguson J, Donnan P, Dawe RS. No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study. Br J Dermatol. 2020;183(3):586-7.
Cluster headache Neurologic/CNS
Headache, decreased sex drive, tremor, and trouble falling asleep have been reported in patients receiving light therapy. Exposure to light therapy for more than 24 hours as an infant is linked to higher odds of development delays in the domains of communication, gross motor, problem solving, and personal-social skills by 3 years of age.
- Tuunainen, A., Kripke, D. F., and Endo, T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004;(2):CD004050.
- Chesson, A. L., Jr., Littner, M., Davila, D., Anderson, W. M., Grigg-Damberger, M., Hartse, K., Johnson, S., and Wise, M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Acade
- Terman, M. and Terman, J. S. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60(11):799-808.
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591.
- Donmez M, Yorguner N, Kora K, Topcuoglu V. Efficacy of bright light therapy in perinatal depression: A randomized, double-blind, placebo-controlled study. J Psychiatr Res 2022;149:315-322.
- Sun W, Yan J, Wu J, Ma H. Efficacy and safety of light therapy as a home treatment for motor and non-motor symptoms of Parkinson disease: A meta-analysis. Med Sci Monit 2022;28:e935074.
- Hotta M, Ueda K, Ikehara S, et al. Phototherapy and risk of developmental delay: the Japan Environment and Children's Study. Eur J Pediatr 2023;182(5):2139-2149.
Constipation Gastrointestinal
Nausea is a commonly reported side effect of light therapy. Changes in appetite, dry mouth, diarrhea, constipation, and abdominal pain have also been reported.
- Morgan, M. and Khan, D. A. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol 2008;100(6):517-526.
- Terman, M. and Terman, J. S. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60(11):799-808.
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591.
Dry eye Ocular/Otic
Light therapy may cause eye strain, visual disturbances, or ocular damage. Eye irritation and dry eyes have also been reported.
- Westrin, A. and Lam, R. W. Seasonal affective disorder: a clinical update. Ann Clin Psychiatry 2007;19(4):239-246.
- Sun W, Yan J, Wu J, Ma H. Efficacy and safety of light therapy as a home treatment for motor and non-motor symptoms of Parkinson disease: A meta-analysis. Med Sci Monit 2022;28:e935074.
- Chesson, A. L., Jr., Littner, M., Davila, D., Anderson, W. M., Grigg-Damberger, M., Hartse, K., Johnson, S., and Wise, M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Acade
Fatigue Musculoskeletal
Muscle pain, weakness, and fatigue have been reported in adults using light therapy.
Obesity Endocrine
Weight loss, dehydration, and changes in body temperature have been reported in adults using light therapy.
- Kumar, P., Chawla, D., and Deorari, A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev 2011;(12):CD007969.
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single dose that fits everyone, and the right approach depends on the device and the reason you are using it. For seasonal affective disorder, a common general approach involves a 10,000-lux light box used for a set time in the morning, sitting a recommended distance from the light with eyes open but not staring at it.
Because brightness, distance, and timing all matter, follow the instructions that come with your specific device. The timing of light exposure is especially important for sleep-related uses — using it at the wrong time can backfire.
Check with your doctor or pharmacist before starting, especially if you have an eye, skin, or mood condition. They can help you pick the right device and schedule.
Light Therapy & Pregnancy
Light Therapy & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 35 references that drive our Light Therapy monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Meduri, N. B., Vandergriff, T., Rasmussen, H., and Jacobe, H. Phototherapy in the management of atopic dermatitis: a systematic review. Photodermatol Photoimmunol Photomed 2007;23(4):106-112. PubMed
- Kumar, P., Chawla, D., and Deorari, A. Light-emitting diode phototherapy for unconjugated hyperbilirubinaemia in neonates. Cochrane Database Syst Rev 2011;(12):CD007969. PubMed
- Pathirana, D., Ormerod, A. D., Saiag, P., Smith, C., Spuls, P. I., Nast, A., Barker, J., Bos, J. D., Burmester, G. R., Chimenti, S., Dubertret, L., Eberlein, B., Erdmann, R., Ferguson, J., Girolomoni, G., Gisondi, P., Giunta, A., Griffiths, C., Honigsmann
- Beani, J. C. and Jeanmougin, M. [Narrow-band UVB therapy in psoriasis vulgaris: good practice guideline and recommendations of the French Society of Photodermatology]. Ann Dermatol Venereol 2010;137(1):21-31.
- Leon, A., Nguyen, A., Letsinger, J., and Koo, J. An attempt to formulate an evidence-based strategy in the management of moderate-to-severe psoriasis: a review of the efficacy and safety of biologics and prebiologic options. Expert Opin Pharmacother 2007; PubMed
- Kroft, E. B., Berkhof, N. J., van de Kerkhof, P. C., Gerritsen, R. M., and de Jong, E. M. Ultraviolet A phototherapy for sclerotic skin diseases: a systematic review. J Am Acad Dermatol 2008;59(6):1017-1030. PubMed
- Tuunainen, A., Kripke, D. F., and Endo, T. Light therapy for non-seasonal depression. Cochrane Database Syst Rev 2004;(2):CD004050. DOI
- Chesson, A. L., Jr., Littner, M., Davila, D., Anderson, W. M., Grigg-Damberger, M., Hartse, K., Johnson, S., and Wise, M. Practice parameters for the use of light therapy in the treatment of sleep disorders. Standards of Practice Committee, American Acade DOI
- Morgan, M. and Khan, D. A. Therapeutic alternatives for chronic urticaria: an evidence-based review, Part 2. Ann Allergy Asthma Immunol 2008;100(6):517-526. PubMed
- Lee, E., Koo, J., and Berger, T. UVB phototherapy and skin cancer risk: a review of the literature. Int J Dermatol 2005;44(5):355-360. PubMed
- Murase, J. E., Lee, E. E., and Koo, J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005;44(12):1016-1021. PubMed
- Morison, W. L., Baughman, R. D., Day, R. M., Forbes, P. D., Hoenigsmann, H., Krueger, G. G., Lebwohl, M., Lew, R., Naldi, L., Parrish, J. A., Piepkorn, M., Stern, R. S., Weinstein, G. D., and Whitmore, S. E. Consensus workshop on the toxic effects of long
- Stern, R. S. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study. J Am Acad Dermatol 2012;66(4):553-562. PubMed
- Stern, R. S. and Lunder, E. J. Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis. Arch Dermatol 1998;134(12):1582-1585. PubMed
- Swerdlow, A. J. and Weinstock, M. A. Do tanning lamps cause melanoma? An epidemiologic assessment. J Am Acad Dermatol 1998;38(1):89-98. PubMed
- Terman, M. and Terman, J. S. Bright light therapy: side effects and benefits across the symptom spectrum. J Clin Psychiatry 1999;60(11):799-808. DOI
- Westrin, A. and Lam, R. W. Seasonal affective disorder: a clinical update. Ann Clin Psychiatry 2007;19(4):239-246. PubMed
- Stern, R. S. and Lange, R. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis. Arch Dermatol 1991;127(3):347-350. DOI
- Hoare, C., Li Wan, Po A., and Williams, H. Systematic review of treatments for atopic eczema. Health Technol Assess 2000;4(37):1-191. DOI
- Whitton, M. E., Pinart, M., Batchelor, J., Lushey, C., Leonardi-Bee, J., and Gonzalez, U. Interventions for vitiligo. Cochrane Database Syst Rev 2010;(1):CD003263. PubMed
- Bedair K, Elhadad A, Hamad S, Ferguson J, Donnan P, Dawe RS. No association between whole-body ultraviolet A1 phototherapy and skin cancers in humans: a cancer registry linkage study. Br J Dermatol. 2020;183(3):586-7. PubMed
- Nussbaumer-Streit B, Thaler K, Chapman A, et al. Second-generation antidepressants for treatment of seasonal affective disorder. Cochrane Database Syst Rev 2021;3(3):CD008591. PubMed
- Ju HJ, Han JH, Kim MS, et al. The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo. J Am Acad Dermatol 2021;84(6):1619-1627.
- Ko MJ, Huang JW, Wu HY, et al. Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study. Acta Derm Venereol 2021;101(2):adv00390. PubMed
- Donmez M, Yorguner N, Kora K, Topcuoglu V. Efficacy of bright light therapy in perinatal depression: A randomized, double-blind, placebo-controlled study. J Psychiatr Res 2022;149:315-322. PubMed
- Bugaiski-Shaked A, Shany E, Mesner O, Sergienko R, Wainstock T. Association between neonatal phototherapy exposure and childhood neoplasm. J Pediatr 2022;245:111-116. PubMed
- Wu YH, Chou CL, Chang HC. Risk of skin cancer after ultraviolet phototherapy in patients with vitiligo: a systematic review and meta-analysis. Clin Exp Dermatol 2022;47(4):692-699. PubMed
- Sun W, Yan J, Wu J, Ma H. Efficacy and safety of light therapy as a home treatment for motor and non-motor symptoms of Parkinson disease: A meta-analysis. Med Sci Monit 2022;28:e935074. PubMed
- Zhu S, Ma X, Ding X, et al. Comparative evaluation of low-level light therapy and ethinyl estradiol and desogestrel combined oral contraceptive for clinical efficacy and regulation of serum biochemical parameters in primary dysmenorrhoea: a prospective ra
- Ravindran S, Pai B S, Shetty VM. Risk of cutaneous carcinogenesis with phototherapy in Indian subpopulation: A 10-year analysis and a review of literature. Dermatol Ther 2022;35(7):e15536. PubMed
- Ahad T, Wang EY, Liu YA, et al. Incidence of skin cancers in patients with eczema treated with ultraviolet phototherapy. J Am Acad Dermatol 2022;87(2):387-389. PubMed
- Abdellatif M, Tawfik GM, Makram AM, et al. Association between neonatal phototherapy and future cancer: an updated systematic review and meta-analysis. Eur J Pediatr 2023;182(1):329-341. PubMed
- Agaoglu E, Erdogan HK, Acer E, Saracoglu ZN, Bilgin M. Narrowband ultraviolet B phototherapy for pityriasis lichenoides: A real-life experience. Photodermatol Photoimmunol Photomed 2023;39(5):520-526. PubMed
- Hotta M, Ueda K, Ikehara S, et al. Phototherapy and risk of developmental delay: the Japan Environment and Children's Study. Eur J Pediatr 2023;182(5):2139-2149. PubMed
- Hotta M, Ueda K, Ikehara S, et al. The Duration of Neonatal Phototherapy and Allergic Disorders: The Japan Environment and Children's Study. Int Arch Allergy Immunol 2023;184(3):211-219. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Light Therapy: Common Questions
What is Light Therapy used for, and does it work?
Does Light Therapy interact with prescription medications?
How are Light Therapy interactions rated?
Is it safe to take Light Therapy with my medications?
Where does this Light Therapy interaction information come from?
What is Light Therapy mainly used for?
Is Light Therapy safe?
When is the best time to use a light box?
Can I use Light Therapy while pregnant or breastfeeding?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Have a question about Light Therapy?
Our pharmacists answer your medication & supplement questions — free.